Congratulations to Dr Mihai and the Clinical Trials Research Unit at Beacon Hospital on their input to the international Oligorecurrent Stereotactic trial which indicates stereotactic radiation can extend long-term survival for some patients with stage-IV cancers while maintaining their quality of life. The study is published in the January issue of International Journal of Radiation […]

Congratulations Jacinta

We are delighted to announce that Jacinta Marron has been appointed to the newly created post of Head of Biometrics at Cancer Trials Ireland. As Head of Biometrics, Jacinta will lead the Biometrics unit of Data Management and Statistics in collaboration with Group Statistician, Imelda Parker. Jacinta joined Cancer Trials Ireland in 2015 and has […]

JAVELIN Head & Neck 100

The JAVELIN Head & Neck 100 trial is the first of its kind to open in Ireland. It increases treatment opportunities for some Irish patients. It is a Phase III double-blind randomised controlled trial (RCT) studying the effect of avelumab, versus placebo, in combination with standard of care CRT in the frontline treatment of patients […]

Publications update

Here’s a list of the 14 publications in academic peer reviewed journals since the last DSSG Digest (Spring) in which Cancer Trials Ireland investigators participated. If you would like your publications included in our next listing please contact Compiled by Dr Orla Casey, Translational Project Manager, Cancer Trials Ireland Publications update

DSSG Autumn 2018

At our Autumn DSSG /Scientific meeting, which coincided with the 2018 Gathering Around Cancer hosted at Croke Park, the GU Cancer Research meeting welcomed our new patient consultant Eddie MacEoin (left). Pictured with Eddie is Eibhlin Mulroe, CEO of Cancer Trials Ireland, and Jonathon Westrup, Chair of the Board of Cancer Trials Ireland. Also pictured […]